Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$278K Buy
2,764
+16
+0.6% +$1.81K 0.08% 74
2025
Q4
$344K Buy
2,748
+12
+0.4% +$1.53K 0.1% 69
2025
Q3
$359K Buy
2,736
+12
+0.4% +$1.57K 0.11% 67
2025
Q2
$337K Buy
2,724
+12
+0.4% +$1.58K 0.11% 68
2025
Q1
$344K Buy
2,712
+12
+0.4% +$1.53K 0.13% 64
2024
Q4
$348K Buy
2,700
+13
+0.5% +$1.5K 0.12% 68
2024
Q3
$305K Buy
2,687
+14
+0.5% +$1.54K 0.11% 60
2024
Q2
$277K Buy
2,673
+14
+0.5% +$1.48K 0.1% 57
2024
Q1
$290K Buy
2,659
+12
+0.5% +$1.38K 0.12% 53
2023
Q4
$297K Buy
2,647
+14
+0.5% +$1.4K 0.13% 51
2023
Q3
$246K Buy
2,633
+12
+0.5% +$1.26K 0.12% 48
2023
Q2
$296K Buy
2,621
+13
+0.5% +$1.39K 0.14% 41
2023
Q1
$289K Buy
+2,608
New +$275K 0.16% 37

Other funds holding ABT

Evexia Wealth's ABT Position: Q1 2026 in Review

Evexia Wealth increased its Abbott (ABT) stake by 0.58% in Q1 2026, buying an estimated $1.81K and bringing the position to 2,764 shares worth $278K. The position accounts for 0.08% of the portfolio, ranked #74.

Evexia Wealth first reported a position in ABT in Q1 2023 and has held it in 13 quarters since. The position peaked at $359K in Q3 2025. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Evexia Wealth held 2,764 shares of Abbott worth $278K as of Q1 2026.
  • Evexia Wealth bought 16 Abbott shares in Q1 2026, an estimated $1.81K.
  • Abbott made up 0.08% of Evexia Wealth's portfolio in Q1 2026, its #74 holding.
  • Evexia Wealth first reported a position in Abbott in Q1 2023 and has held it in 13 quarters since.
  • Evexia Wealth's Abbott position peaked at $359K in Q3 2025.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Evexia Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.